Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Principles of method if other than guideline:
The acute dermal toxicity was investigated in a group af 5 male and 5 female rats (treated with the undiluted liquid test substance, 400 mg/kg bw). Since no mortality occurred, a dose of 1000 mg/kg (test substance emulsion in olive oil) was tested with 5 female rats.
Due to necrotic skin changes caused by the test substance preparation, a further application of 1000 mg/kg with 5 male rats was not performed.
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Acrylic acid, monoester with propane-1,2-diol
EC Number:
247-118-0
EC Name:
Acrylic acid, monoester with propane-1,2-diol
Cas Number:
25584-83-2
Molecular formula:
C6H10O3
IUPAC Name:
Reaction mass of 2-hydroxy-1-methylethyl acrylate and 2-hydroxypropyl acrylate
Details on test material:
- Name of test material (as cited in study report): Hydroxypropyl acrylate
- Analytical purity: 98.9 area % (GC)
- Substance No.: 98/185-1
- Lot/batch No.: Beh. 10, 15:30

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Strain: Wistar / chbb: thom (SPF)
- Source: Boehringer Ingelheim Pharma KG
- Age at study initiation: Young adult animals
- Weight at study initiation: 200 g - 300 g
- Fasting period before study: no
- Housing: Single housing
- Diet (ad libitum): Kliba-Labordiaet, Klingentalmuehle AG Kaiseraugst, Switzerland
- Water (ad libitum): Tap water
- Acclimation period: at least 1 week.


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
olive oil
Details on dermal exposure:
TEST SITE
- Area of exposure: dorsal and dorsolateral parts of the trunk
- % coverage: About 50 cm2 (corresponds to at least 10 % of the body surface area
- Type of wrap if used: four layers absorbent gauze, Ph. Eur. Lohmann GmbH & Co. KG and Ficomull stretch (adhesive fleece), Beiersdorf AG


REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes, with warm water
- Time after start of exposure: 24 hr


TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.38 mL/kg bw undiluted (= 400 mg/kg bw) and 4 mL/kg bw in olive oil (= 1000 mg/kg bw)
- Concentration (if solution): 25 g/ 100 mL
- Constant volume or concentration used: no


VEHICLE
- Lot/batch no.: Olive oil DAB 10
Duration of exposure:
24 hr
Doses:
400 mg/kg (undiluted test substance), 1000 mg/kg (emulsion in olive oil)
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
- A check for any dead or moribund animal was made twice each workday and once on saturdays, sundays and on public holidays.
- Individual body weights shortly before application (day 0), weekly thereafter and at the end of the study (before fasting period).
- Recording of signs and symptoms several times on the day of administration, at least once each workday for the individual animals.
- Individual readings of skin findings 30 - 60 minutes after removal of the semiocclusive dressing (day 1), day 4 (only 400 mg/kg), day 7 and at the end of the study (last day of the observation period).
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, histopathology, assessment of skin findings according to Draize JH (1959): Appraisal of the safety of chemicals in foods, drugs and cosmetics. The association of food and drug officials of the United States Austin, Texas.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 1 000 mg/kg bw
Mortality:
No mortality occurred.
Clinical signs:
other: No systemic toxicity was noted in any of the animals.
Gross pathology:
- Necropsy: lesions or necrosis in the region of the application area were noted at the end of the study at 1000 mg/kg bw.
- Histopathology: Histopathological examination of 1 animal of the 1000 mg/kg bw dose group revealed focal necrosis (full thickness necrosis), perifocal hyperplasia, squamous cell and perifocal inflammation.
Other findings:
Local skin effects:
Local effects observed in the 400 and 1000 mg/kg bw dose groups were very slight, well-defined and moderate to severe erythema, very slight and slight edema, scaling, severe scaling, crust formation, bleeding and petechiae. Visual necrosis was seen in 1 female rat of the 400 mg/kg bw group and in 2 females of the 1000 mg/kg bw group.

Any other information on results incl. tables

In the present study, the acute LD50 was found to be > 1000 mg/kg bw for the female animals. Due to animal welfare reason (necrosis of the skin) male animals were not tested. However, in another study performed in parallel with a similar test substance (2-Hydroxyethyl acrylate), no mortality occurred after application of 1000 mg/kg bw to 5 male rats. Thus, the acute dermal LD50 of Hydroxypropyl acrylate is considered to be > 1000 mg/kg bw for male and female animals.

Body weights [g]:

Dose [mg/kg bw]

400

1000

 

male

female

female

Day 0

264

217

227

Day 7

288

227

230

Day 13

316

244

284

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria